Abrams & Bayliss LLP
General
Cases82
Challenger50%
Patent Owner50%
NPE50%
Practice Areas
BiotechComp. Arch. and SoftwareCommunications
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
---|---|---|
09/18/24 | REDACTED VERSION of [133] Stipulation by AstraZeneca Pharmaceuticals, LP, ZS Pharma, Inc.. (Silver, Daniel) (Entered: 09/18/2024) | |
09/18/24 | CONSENT JUDGMENT between Plaintiffs and Defendant Sandoz Inc. (*Party Sandoz Inc. terminated). Signed by Judge Jennifer L. Hall on 9/18/2024. (ceg) (Entered: 09/18/2024) | |
09/17/24 | Pro Hac Vice Fee - Credit Card Payment received for Diva Hollis. ( re [618] MOTION for Pro Hac Vice Appearance of Attorney Diva Hollis )( Payment of $ 50, receipt number ADEDC-4500269).(Silver, Daniel) (Entered: 09/17/2024) | |
09/17/24 | MOTION for Pro Hac Vice Appearance of Attorney Diva Hollis - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # [1] Certification of Diva Hollis)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 09/17/2024) | |
09/16/24 | REDACTED VERSION of [1528] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H, # [3] Exhibit I)(Gattuso, Dominick) (Entered: 09/16/2024) | |
09/16/24 | REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # [297] . (nms) (Entered: 09/16/2024) | |
09/16/24 | DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [1539] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [1528] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [1528] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024) | |
09/06/24 | Joint Status Report Regarding Stay, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GMBH. (Fahnestock, Derek) Modified on 9/6/2024 (nms). (Entered: 09/06/2024) | |
07/18/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,096,918. (Attachments: # 1 Consent Judgment (redacted version))(nms) (Entered: 07/18/2024) | |
07/03/24 | NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 98 Notice of Appeal (Federal Circuit) filed by CoolTVNetwork.com, Inc. USCA Case Number 2024-2030. (ceg) (Entered: 07/03/2024) |